Angiogenesis in cancer, vascular, rheumatoid and other disease, Nature Medicine, vol.326, issue.1, pp.27-31, 1995. ,
DOI : 10.1038/359845a0
Angiogenesis in cancer and other diseases, Nature, vol.407, issue.6801, pp.249-257, 2000. ,
DOI : 10.1038/35025220
Angiogenesis in life, disease and medicine, Nature, vol.Teill II, issue.7070, pp.932-936, 2005. ,
DOI : 10.1038/nature04478
Antiangiogenic and antivascular therapy for cancer, Current Opinion in Pharmacology, vol.1, issue.4, pp.378-384, 2001. ,
DOI : 10.1016/S1471-4892(01)00065-0
Disrupting tumour blood vessels, Nature Reviews Cancer, vol.48, issue.8, pp.423-435, 2005. ,
DOI : 10.1038/sj.bjc.6690416
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer, New England Journal of Medicine, vol.350, issue.23, pp.2335-2342, 2004. ,
DOI : 10.1056/NEJMoa032691
Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial, Journal of Clinical Oncology, vol.23, issue.16, pp.3697-3705, 2005. ,
DOI : 10.1200/JCO.2005.05.112
Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer, Journal of Clinical Oncology, vol.23, issue.4, pp.792-799, 2005. ,
DOI : 10.1200/JCO.2005.05.098
Cancer chemoprevention with dietary phytochemicals, Nature Reviews Cancer, vol.3, issue.10, pp.768-780, 2003. ,
DOI : 10.1038/nrc1189
Flavonoids as Anticancer Agents: Structure-Activity Relationship Study, Current Medicinal Chemistry-Anti-Cancer Agents, vol.2, issue.6, pp.691-714, 2002. ,
DOI : 10.2174/1568011023353714
The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer, Pharmacol Rev, vol.52, pp.673-751, 2000. ,
The biochemistry and medical significance of the flavonoids, Pharmacology & Therapeutics, vol.96, issue.2-3, pp.67-202, 2002. ,
DOI : 10.1016/S0163-7258(02)00298-X
Vascular collapse after flavone acetic acid: A possible mechanism of its anti-tumour action, European Journal of Cancer and Clinical Oncology, vol.25, issue.10, pp.1419-1424, 1989. ,
DOI : 10.1016/0277-5379(89)90099-0
Crystal Structure of a Human Cyclin-Dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin, Journal of Medicinal Chemistry, vol.48, issue.3, pp.737-743, 2005. ,
DOI : 10.1021/jm049353p
Chromosomal malsegregation and micronucleus induction in vitro by the DNA topoisomerase II inhibitor fisetin, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol.582, issue.1-2, pp.79-86, 2005. ,
DOI : 10.1016/j.mrgentox.2005.01.002
Flavonoids as DNA Topoisomerase Antagonists and Poisons: Structure-Activity Relationships, Journal of Natural Products, vol.58, issue.2, pp.217-225, 1995. ,
DOI : 10.1021/np50116a009
Nutraceutical inhibitors of urokinase: Potential applications in prostate cancer prevention and treatment, Oncology Reports, vol.16, pp.341-346, 2006. ,
DOI : 10.3892/or.16.2.341
Flavonoids Affect Actin Functions in Cytoplasm and Nucleus, Biophysical Journal, vol.93, issue.8, pp.2767-2780, 2007. ,
DOI : 10.1529/biophysj.107.107813
A Novel Dietary Flavonoid Fisetin Inhibits Androgen Receptor Signaling and Tumor Growth in Athymic Nude Mice, Cancer Research, vol.68, issue.20, pp.8555-8563, 2008. ,
DOI : 10.1158/0008-5472.CAN-08-0240
Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint, Carcinogenesis, vol.30, issue.6, pp.1032-1040, 2009. ,
DOI : 10.1093/carcin/bgp101
Permanent cell line expressing human factor VIII-related antigen established by hybridization., Proceedings of the National Academy of Sciences, vol.80, issue.12, pp.3734-3737, 1983. ,
DOI : 10.1073/pnas.80.12.3734
Image processing with ImageJ, Biophotonics International, vol.11, pp.36-42, 2004. ,
Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water, Cancer Res, vol.62, pp.2731-2735, 2002. ,
Potentiation of the antitumour effect of cyclophosphamide in mice by thalidomide, Cancer Chemotherapy and Pharmacology, vol.50, issue.3, pp.186-192, 2002. ,
DOI : 10.1007/s00280-002-0482-y
Marked potentiation of the antitumour activity of chemotherapeutic drugs by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA), Cancer Chemotherapy and Pharmacology, vol.51, issue.1, pp.43-52, 2003. ,
DOI : 10.1007/s00280-002-0529-0
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer, Cancer Res, vol.60, pp.1878-1886, 2000. ,
E-selectin is present in proliferating endothelial cells in human hemangiomas, Am J Pathol, vol.148, pp.1181-1191, 1996. ,
Metabolism and Pharmacokinetics of 3,3???,4???,7-Tetrahydroxyflavone (Fisetin), 5-Hydroxyflavone, and 7-Hydroxyflavone and Antihemolysis Effects of Fisetin and Its Serum Metabolites, Journal of Agricultural and Food Chemistry, vol.57, issue.1, pp.83-89, 2009. ,
DOI : 10.1021/jf802378q
Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock, Life Sciences, vol.74, issue.6, pp.743-756, 2003. ,
DOI : 10.1016/j.lfs.2003.07.017
Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems, Cancer Res, vol.52, pp.6567-6575, 1992. ,
Treatment of Corneal Neovascularization with Dietary Isoflavonoids and Flavonoids, Experimental Eye Research, vol.71, issue.5, pp.483-487, 2000. ,
DOI : 10.1006/exer.2000.0900
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents, Investigational New Drugs, vol.15, issue.1, pp.39-48, 1997. ,
DOI : 10.1023/A:1005718628223
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors, Advances in Enzyme Regulation, vol.22, pp.27-55, 1984. ,
DOI : 10.1016/0065-2571(84)90007-4
Upregulation of urokinase receptor expression on migrating endothelial cells, The Journal of Cell Biology, vol.122, issue.3, pp.673-684, 1993. ,
DOI : 10.1083/jcb.122.3.673